Study of advanced treatments for psoriatic arthritis based on sex and gender
Part of Bones, joints & muscles, Skin clinical trials.
This study looks at how well advanced treatments work for people with psoriatic arthritis, and whether results differ for sex and gender. You may be eligible if your psoriatic arthritis is active and you are planning to start an advanced treatment for symptoms in the joints and surrounding areas.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a rheumatologist-confirmed diagnosis of psoriatic arthritis using the CASPAR criteria
- You are 18 years old or older
- Your psoriatic arthritis is currently active, with symptoms like joint inflammation, swollen fingers/toes (dactylitis), or inflamed tendon/ligament areas (enthesitis) found on exam
- You plan to start an advanced treatment aimed at your peripheral musculoskeletal (joint/limb) symptoms
- You can read or write, understand the study, sign consent, and come back for follow-up visits regularly
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how psoriatic arthritis affects your daily life and how that relates to the severity of your condition. It aims to better understand the disease to improve future care.
This study tests targeted medications for people with active psoriatic arthritis (PsA) who have already tried 1 or 2 other advanced treatments without success or couldn't tolerate them. The goal is to see if these newer options can better control joint pain and skin symptoms.
This study compares two “treat-to-target” strategies for psoriatic arthritis. One strategy uses imaging to guide treatment changes, and the other uses standard clinic assessments, to see which approach controls symptoms more effectively.
This study tests a combined program of intense aerobic and strength training to see if it improves disease activity and function in people with psoriatic arthritis. You would either join the training group or continue your usual care, and researchers will track your progress over 3 months.
This study looks at people with early arthritis related to rheumatoid arthritis, psoriatic arthritis, or psoriasis. Researchers want to understand how these early conditions behave and may help guide better treatment decisions.
This study looks at how inflammatory “cytokines” are expressed in people with psoriasis—both those with joint involvement and those without. It may help researchers understand what drives joint disease and guide better future monitoring or treatments.
Hear when a new Psoriatic Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.